Advertisement

Editorial: The role of medical physics in lung SBRT

Published:January 09, 2018DOI:https://doi.org/10.1016/j.ejmp.2018.01.001

      Highlights

      • Medical physicists helped in the starting of SBRT for non-operable NSCLC patients.
      • This special issue focused on physics challenges in lung SBRT.
      • Physicists could lead the safe implementation of SBRT.

      Abstract

      Stereotactic body radiation therapy (SBRT) has become a standard treatment for non-operable patients with early stage non-small cell lung cancer (NSCLC). In this context, medical physics community has largely helped in the starting and the growth of this technique. In fact, SBRT requires the convergence of many different features for delivering large doses in few fractions to small moving target in an heterogeneous medium. The special issue of last month, was focused on the different physics challenges in lung SBRT. Eleven reviews were presented, covering: imaging for treatment planning and for treatment assessment; dosimetry and planning optimization; treatment delivery possibilities; image guidance during delivery; radiobiology. The current cutting edge role of medical physics was reported. We aimed to give a complete overview of different aspects of lung SBRT that would be of interest to both physicists implementing this technique in their institutions and more experienced physicists that would be inspired to start research projects in areas that still need further developments. We also feel that the role that medical physicists have played in the development and safe implementation of SBRT, particularly in lung region, can be taken as an excellent example to be translated to other areas, not only in Radiation Oncology but also in other health sectors.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Physica Medica: European Journal of Medical Physics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Baumann P.
        • Nyman J.
        • Hoyer M.
        • Wennberg B.
        • Gagliardi G.
        • Lax I.
        • et al.
        Outcome in a prospective phase II trial of medically inoperable stage I non small-cell lung cancer patients treated with stereotactic body radiotherapy.
        J Clin Oncol. 2009; 27: 3290-3296
        • Timmerman R.
        • Paulus R.
        • Galvin J.
        • Michalski J.
        • Straube W.
        • Bradley J.
        • et al.
        Stereotactic body radiation therapy for inoperable early stage lung cancer.
        J Am Med Assoc. 2010; 303: 1070-1076
        • Chang J.Y.
        • et al.
        Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.
        Lancet Oncol. 2015; 16: 630-637
        • Ettingen D.
        • Wood D.
        • Aisner D.
        • et al.
        Non-small cell lung cancer, version 5.2017.
        J Nation Compre Cancer Network. 2017; 15: 504-535
        • Russo S.
        • Reggiori G.
        • Cagni E.
        • et al.
        Small field output factors evaluation with a microdiamond detector over 30 Italian centers.
        Phys Med. 2016; 32: 1644-1650https://doi.org/10.1016/j.ejmp.2016.10.017
        • Vieillevigne L.
        • Bessieres S.
        • Ouali M.
        • Lanaspeze C.
        Dosimetric comparison of flattened and unflattened beams for stereotactic body radiation therapy: impact of the size of the PTV on dynamic conformal arc and volumetric modulated arc therapy.
        Phys Med. 2016; 32: 1405-1414https://doi.org/10.1016/j.ejmp.2016.10.007
        • Stavrev P.
        • Ruggieri R.
        • Stavreva N.
        • Naccarato S.
        • Alongi F.
        Applying radiobiological plan ranking methodology to VMAT prostate SBRT.
        Phys Med. 2016; 32: 636-641https://doi.org/10.1016/j.ejmp.2016.03.019
        • Mancosu P.
        • Clemente S.
        • Landoni V.
        • et al.
        SBRT for prostate cancer: challenges and features from a physicist prospective.
        Phys Med. 2016; 32: 479-484https://doi.org/10.1016/j.ejmp.2016.03.011. Review
        • Kawahara D.
        • Ozawa S.
        • Kimura T.
        • et al.
        Availability of applying diaphragm matching with the breath-holding technique in stereotactic body radiation therapy for liver tumors.
        Phys Med. 2016; 32: 557-561https://doi.org/10.1016/j.ejmp.2016.02.007
        • Esposito M.
        • Maggi G.
        • Marino C.
        • et al.
        Multicentre treatment planning inter-comparison in a national context: the liver stereotactic ablative radiotherapy case.
        Phys Med. 2016; 32: 277-283https://doi.org/10.1016/j.ejmp.2015.09.009
        • Friedrich T.
        • Scholz U.
        • Durante M.
        • Scholz M.
        RBE of ion beams in hypofractionated radiotherapy (SBRT).
        Phys Med. 2014; 30: 588-591https://doi.org/10.1016/j.ejmp.2014.04.009
        • Lin Y.W.
        • Lin K.H.
        • Ho H.W.
        • Lin H.M.
        • Lin L.C.
        • Lee S.P.
        • et al.
        Treatment plan comparison between stereotactic body radiation therapy techniques for prostate cancer: non-isocentric CyberKnife versus isocentric RapidArc.
        Phys Med. 2014; 30: 654-661https://doi.org/10.1016/j.ejmp.2014.03.008
        • Udrescu C.
        • Rouvière O.
        • Enachescu C.
        • Sotton M.P.
        • Bouffard-Vercelli J.
        • Jalade P.
        • et al.
        Potential interest of developing an integrated boost dose escalation for stereotactic irradiation of primary prostate cancer.
        Phys Med. 2014; 30: 320-325https://doi.org/10.1016/j.ejmp.2013.09.005
        • Bouilhol G.
        • Ayadi M.
        • Rit S.
        • Thengumpallil S.
        • Schaerer J.
        • Vandemeulebroucke J.
        • et al.
        Is abdominal compression useful in lung stereotactic body radiation therapy? a 4DCT and dosimetric lobe-dependent study.
        Phys Med. 2013; 29: 333-340https://doi.org/10.1016/j.ejmp.2012.04.006
        • Jang S.S.
        • Huh G.J.
        • Park S.Y.
        • Yang P.S.
        • Cho E.Y.
        The impact of respiratory gating on lung dosimetry in stereotactic body radiotherapy for lung cancer.
        Phys Med. 2014; 30: 682-689https://doi.org/10.1016/j.ejmp.2014.05.005
        • Harada K.
        • Katoh N.
        • Suzuki R.
        • et al.
        Evaluation of the motion of lung tumors during stereotactic body radiation therapy (SBRT) with four-dimensional computed tomography (4DCT) using real-time tumor-tracking radiotherapy system (RTRT).
        Phys Med. 2016; 32: 305-311https://doi.org/10.1016/j.ejmp.2015.10.093
        • Giglioli F.R.
        • Strigari L.
        • Ragona R.
        • et al.
        Lung stereotactic ablative body radiotherapy: a large scale multi-institutional planning comparison for interpreting results of multi-institutional studies.
        Phys Med. 2016; 32: 600-606https://doi.org/10.1016/j.ejmp.2016.03.015
        • Anderle K.
        • Stroom J.
        • Pimentel N.
        • Greco C.
        • Durante M.
        • Graeff C.
        In silico comparison of photons versus carbon ions in single fraction therapy of lung cancer.
        Phys Med. 2016; 32: 1118-1123https://doi.org/10.1016/j.ejmp.2016.08.014
        • Garibaldi C.
        • Piperno G.
        • Ferrari A.
        • et al.
        Translational and rotational localization errors in cone-beam CT based image-guided lung stereotactic radiotherapy.
        Phys Med. 2016; 32: 859-865https://doi.org/10.1016/j.ejmp.2016.05.055
        • Riccardi U.
        • Badellino S.
        • Filippi A.R.
        • et al.
        What do the radiation oncologists require for future advancements in lung SBRT.
        Phys Med. 2017; 44: 150-156https://doi.org/10.1016/j.ejmp.2016.11.114
        • Lebredonche S.
        • Lacornerie T.
        • Rault E.
        • Wagner A.
        • Reynaert N.
        • Crop F.
        About the non-consistency of PTV-based prescription in lung.
        Phys Med. 2017; 44: 177-187https://doi.org/10.1016/j.ejmp.2017.03.009
        • Sarrut D.
        • Baudier T.
        • Ayadi M.
        • Tanguy R.
        • Rit S.
        Deformable image registration applied to lung SBRT: usefulness and limitations.
        Phys Med. 2017; 44: 108-112https://doi.org/10.1016/j.ejmp.2017.09.121
        • Giglioli R.
        • Clemente S.
        • Esposito M.
        • et al.
        Frontiers in planning optimization for lung SBRT.
        Phys Med. 2017; 44: 163-170https://doi.org/10.1016/j.ejmp.2017.05.064
        • Fogliata A.
        • Cozzi L.
        Dose calculation algorithm accuracy for small fields in non-homogeneous media: the lung SBRT case.
        Phys Med. 2017; 44: 157-162https://doi.org/10.1016/j.ejmp.2016.11.104
        • McCurdy B.M.C.
        • McCowan P.M.
        In vivo dosimetry for lung radiotherapy including SBRT.
        Phys Med. 2017; 44: 123-130https://doi.org/10.1016/j.ejmp.2017.05.065
        • Clark C.H.
        • Hurkmans C.W.
        • Cry S.
        The role of dosimetry audit in lung SBRT multi-centre clinical trials.
        Phys Med. 2017; 44: 171-176https://doi.org/10.1016/j.ejmp.2017.04.003
        • Caillet V.
        • Booth J.T.
        • Keall P.
        IGRT and motion management during lung SBRT delivery.
        Phys Med. 2017; 44: 113-122https://doi.org/10.1016/j.ejmp.2017.06.006
        • Manten M.J.
        • Wetscherek A.
        • Fast M.F.
        MRI-guided lung SBRT: Present and future developments.
        Phys Med. 2017; 44: 139-149https://doi.org/10.1016/j.ejmp.2017.02.003
        • Ruggeri R.
        • Stavrev P.
        • Naccarato S.
        • Stavreva N.
        • Alongi F.
        • Nahum A.E.
        Optimal dose and fraction number in SBRT of lung tumours: a radiobiological analysis.
        Phys Med. 2017; 44: 188-195https://doi.org/10.1016/j.ejmp.2016.12.012
        • De Rose F.
        • Franceschini D.
        • Reggiori G.
        • et al.
        Organs at risk in lung SBRT.
        Phys Med. 2017; 44: 131-138https://doi.org/10.1016/j.ejmp.2017.04.010